Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Kabra Drugs Ltd

NSE: KABRADG · BSE: 524322 · Pharmaceuticals & Biotechnology · 28 announcements

Share price
₹18.65
Market cap
₹44.22 Cr
Revenue (annual)
₹92.74 Cr
Net profit (annual)
₹4.96 Cr
P/E (TTM)
5.8×Sector 47.4×
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15:56 IST BSE
Capacity Expansion

Kabra Drugs Capacity Expansion: ₹200 Cr Investment

Kabra Drugs plans a ₹200 Crore pharmaceutical plant in Chhattisgarh. This expansion aims to boost manufacturing capacity and long-term growth.

Value
₹200.0 Cr
18:51 IST BSE
Capacity Expansion

Kabra Drugs Capacity Expansion

Kabra Drugs Limited announced strategic expansion into pharmaceutical manufacturing and AI-integrated defense technologies. Key initiatives include establishing an R&D facility at Cactus TECCI Park, Chennai, and obtaining a SCOMET license. The company also appointed Mr. Alagiamanavalan as an Independent Consultant for defense projects to drive diversification and long-term value creation.

Execution
Phase 1 focusing on South India; project implementation initiated immediately